Halia Therapeutics, a clinical-stage biopharmaceutical company advancing medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, has opened its new 20,000 sq.-ft. headquarters in Lehi, UT.   The new building will house a variety of state-of-the-art research and development lab equipment managed by 18 current, full-time employees and contractors. The facility is dedicated to the development of novel therapies for patients with inflammatory and neurolog...